Literature DB >> 19239803

Update on neurosyphilis.

Christina M Marra1.   

Abstract

Neurosyphilis literally means syphilitic infection of the central nervous system, but it is often referred to incorrectly as "tertiary syphilis." Neurosyphilis can occur at any time in the course of syphilis, even in the earliest, primary, stage. Early forms of neurosyphilis primarily affect the meninges, cerebrospinal fluid, and cerebral or spinal cord vasculature. Late forms of neurosyphilis primarily affect the brain and spinal cord parenchyma. Uveitis and hearing loss related to syphilis are most common in early syphilis and may be accompanied by early neurosyphilis. The treatment for syphilis-related eye disease and hearing loss is the same as the treatment for neurosyphilis. Neurosyphilis is more commonly seen in patients infected with HIV, and much of the recent literature pertains to this risk group. This article provides a critical review of recent literature on the diagnosis, clinical findings, risk factors, and management of neurosyphilis.

Entities:  

Year:  2009        PMID: 19239803     DOI: 10.1007/s11908-009-0019-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  59 in total

1.  Neurosyphilis presenting as herpes simplex encephalitis.

Authors:  I Szilak; F Marty; J Helft; R Soeiro
Journal:  Clin Infect Dis       Date:  2001-03-20       Impact factor: 9.079

2.  Treatment of neurosyphilis with ceftriaxone.

Authors:  S Shann; J Wilson
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

3.  Otosyphilis: a review of 85 cases.

Authors:  Kwanchanok Yimtae; Somchai Srirompotong; Krisna Lertsukprasert
Journal:  Otolaryngol Head Neck Surg       Date:  2007-01       Impact factor: 3.497

4.  Recurrent syphilitic uveitis.

Authors:  B W Richards; T J Hessburg; J N Nussbaum
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

5.  Syphilitic acute posterior placoid chorioretinitis in nonimmuno-compromised patients.

Authors:  A Joseph; S Rogers; A Browning; N Hall; C Barber; A Lotery; E Foley; W M Amoaku
Journal:  Eye (Lond)       Date:  2006-10-06       Impact factor: 3.775

6.  Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada.

Authors:  Sharmistha Mishra; Sharon Lynn Walmsley; Mona Rafik Loutfy; Rupert Kaul; Kenneth John Logue; Wayne Lawrence Gold
Journal:  AIDS Patient Care STDS       Date:  2008-03       Impact factor: 5.078

7.  Otosyphilis: report on six cases.

Authors:  E Klemm; U Wollina
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-07       Impact factor: 6.166

8.  Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis.

Authors:  P G van der Valk; E J Kraai; P C van Voorst Vader; H Haaxma-Reiche; J A Snijder
Journal:  Genitourin Med       Date:  1988-08

9.  Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.

Authors:  Christina M Marra; Clare L Maxwell; Stacy L Smith; Sheila A Lukehart; Anne M Rompalo; Molly Eaton; Bradley P Stoner; Michael Augenbraun; David E Barker; James J Corbett; Mark Zajackowski; Charles Raines; Judith Nerad; Romina Kee; Scott H Barnett
Journal:  J Infect Dis       Date:  2004-01-27       Impact factor: 5.226

10.  Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection.

Authors:  Ji Hun Song; Young Taek Hong; Oh Woong Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-27       Impact factor: 3.117

View more
  40 in total

1.  Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China.

Authors:  Lin Zhu; Xin Gu; Rui-Rui Peng; Cuini Wang; Zixiao Gao; Pingyu Zhou; Ying Gao; Mei Shi; Zhifang Guan; Arlene C Seña
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

Review 2.  Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis.

Authors:  Maggie Kuhn; Selena E Heman-Ackah; Jamil A Shaikh; Pamela C Roehm
Journal:  Trends Amplif       Date:  2011-05-22

3.  Neurosyphilis Update: Atypical is the New Typical.

Authors:  Salman Bhai; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

4.  Imaging in neurologic infections I: bacterial and parasitic diseases.

Authors:  Pooja Raibagkar; Martha R Neagu; Jennifer L Lyons; Joshua P Klein
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 5.  Recent trends in the serologic diagnosis of syphilis.

Authors:  Muhammad G Morshed; Ameeta E Singh
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

6.  Neurocognitive and psychiatric changes as the initial presentation of neurosyphilis.

Authors:  Cecilia T Costiniuk; Paul A MacPherson
Journal:  CMAJ       Date:  2013-02-25       Impact factor: 8.262

7.  An immunocompetent migrant presenting with neurosyphilis with an unusual unilateral papillitis: a case report.

Authors:  Paolo Turchetti; Fernanda Pacella; Elena Pacella; Concetta Mirisola; Ilaria Uccella
Journal:  Eur J Med Res       Date:  2012-02-14       Impact factor: 2.175

8.  Posterior spinal cord infarctions due to neurosyphilis.

Authors:  Olivier Bill; Renaud A Du Pasquier; Patrik Michel
Journal:  Neurol Clin Pract       Date:  2014-12

Review 9.  Late-stage neurosyphilis presenting with severe neuropsychiatric deficits: diagnosis, therapy, and course of three patients.

Authors:  Sabine Ulrike Jantzen; Stefano Ferrea; Tania Langebner; Wolfgang Gaebel; Mechthild Griese; Gabriele Arendt; Marcel Dihné
Journal:  J Neurol       Date:  2011-10-01       Impact factor: 4.849

10.  Detection of Treponema pallidum Sp. Pallidum DNA in Cerebrospinal Fluid (CSF) by Two PCR Techniques.

Authors:  Rita Castro; Maria João Águas; Teresa Batista; Carlos Araújo; Kamal Mansinho; Filomena da Luz Martins Pereira
Journal:  J Clin Lab Anal       Date:  2016-02-18       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.